Beranda » Blog » Kirin Holdings Initiates Tender Offer To Make FANCL A Wholly Owned Subsidiary

Kirin Holdings Initiates Tender Offer To Make FANCL A Wholly Owned Subsidiary

Diposting pada 14 Juni 2024 oleh admin / Dilihat: 0 kali

• Contribute to the health of consumers worldwide through our health food and skin care businesses

• Aims to become one of the largest health sciences companies in Asia-Pacific

• Concurrent with the Blackmores acquisition, enhancing the Group’s value creation and further strengthening its global operating base

Tokyo–(ANTARA/Business Wire)– Kirin Holdings Company, Limited (Kirin Holdings) (TOKYO: 2503) has decided to acquire additional ordinary shares of FANCL Corporation (FANCL) (TOKYO: 4921) through a tender offer and share warrants under the Law -Financial Instruments and Exchange Act (Law No. 25 of 1948, as amended) by making FANCL a wholly owned subsidiary.

• Background

Under the long-term management vision Kirin Group Vision 2027, Kirin Holdings aims to “become a global leader in CSV by creating value in domains ranging from food & beverage to pharmaceuticals” by launching businesses in health sciences areas in addition to food and pharmaceuticals, and by turning consumer health issues into growth opportunities. Through its research and development capabilities in the fields of fermentation and biotechnology and immunology, Kirin Holdings has strengthened its health sciences business to develop it into a business unit that will be responsible for the long-term growth of the Kirin Group. In 2019, Kirin Holdings acquired approximately 33% of FANCL shares (based on voting rights) and signed a capital and business alliance agreement. In 2023, Kirin Holdings acquired Blackmores Limited (Blackmores), an Australian company operating a health food (natural health) business in the Asia-Pacific region, thereby gaining a solid business foundation in overseas markets.

Under FANCL Group VISION2030, FANCL aims to make the world healthier and more beautiful while becoming a company loved all over the world. By responding to the changing social environment through measures such as solving new problems caused by COVID-19, FANCL has strengthened its relationship with consumers and strengthened its foundation for sustainable growth. Going forward, FANCL aims to further strengthen its domestic operating base and aggressively invest cash generated in Japan in FANCL’s overseas operations to develop them into growth drivers.

Supported by the same philosophy and direction in achieving their own growth through solving health social problems, Kirin Holdings and FANCL have deepened mutual understanding through the exchange of human resources since the conclusion of the capital and business alliance agreement in 2019. In addition, while experiencing changes in the external environment together, like COVID-19, the two companies have collaborated in the areas of materials, product and brand development, joint research and business development, and the use of shared infrastructure.

• Aim to make FANCL a wholly owned subsidiary

Kirin Holdings’ strengths include its long-standing immunology research, its ability to develop and produce high-value-added ingredients through fermentation and biotechnology, and its health food business base in Asia-Pacific, acquired through the acquisition of Blackmores.

FANCL’s strength lies in its ability to connect and understand consumers through D2C channels (online and direct-managed store sales), which account for 70% of sales, and in its technology to commercialize products by leveraging consumer feedback in research and development. in order to eliminate “negative things” with a sense of justice that has been continuously pursued since its founding.

With FANCL as a wholly owned subsidiary, Kirin Holdings will accelerate the creation of a competitive business model by complementing each company’s unique strengths through the utilization of management resources and integrated management promotion. By commercializing ingredients made through natural fermentation technology, leveraging customer insights gained from Kirin Holdings and FANCL’s strong relationships with consumers, and delivering them to consumers through multiple channels in the Asia-Pacific region, Kirin Group will contribute to solving consumer problems. health issues in both the cosmetics and health food businesses and is increasingly increasing its presence in global markets other than Japan.

The conversion of FANCL into a wholly owned subsidiary is expected to generate capabilities that far exceed the current capital and business alliance framework, such as strengthening mutual use of operating bases and purchasing data in Japan and abroad, deepening joint research. , and horizontal application of environmental technology. As the core company running Kirin Group’s health sciences business, FANCL will further enhance the “FANCL-ness” of its brand without changing its founding philosophy, which is the source of its strength. In addition to maximizing FANCL’s enterprise value, the two companies will work closely together to promote the business to develop it into one of the largest health sciences businesses in the Asia-Pacific region, thereby achieving growth for the Kirin Group as a whole and further enhancing the company’s value.

About Kirin Holdings

Kirin Holdings Company, Limited is an international company operating in the Food & Beverage domain (Food & Beverage business), Pharmaceutical domain (Pharmaceutical business), and Health Sciences domain (Health Sciences business), both in Japan and worldwide.

Kirin Holdings has its origins in Japan Brewery founded in 1885. Japan Brewery became Kirin Brewery in 1907. Since then, the company has expanded its business with fermentation and biotechnology as its core technologies, and entered the pharmaceutical business in the 1980s, all of which it continues to be central to. global growth. In 2007, Kirin Holdings was founded as a pure holding company and currently focuses on improving the Health Sciences domain.

Under Kirin Group Vision 2027 (KV 2027), a long-term management plan launched in 2019, Kirin Group aims to become a global leader in CSV*, creating value across the world, from Food & Beverage to Pharmaceuticals. Going forward, Kirin Group will continue to leverage its strengths to create social and economic value through its businesses, with the aim of achieving sustainable growth in corporate value.

* Creating Shared Value: combining added value for consumers and society at large.

Contact

press contact

Kirin Holdings Company, Limited Corporate Communications Department

Nakano Central Park South, 4-10-2 Nakano, Nakano-ku, Tokyo

Source: Kirin Holdings Company, Limited

Reporter: PR Wire
Editor: PR Wire
Copyright © ANTARA 2024

Bagikan ke

Kirin Holdings Initiates Tender Offer To Make FANCL A Wholly Owned Subsidiary

Saat ini belum tersedia komentar.

Mohon maaf, form komentar dinonaktifkan pada halaman/artikel ini.

Kirin Holdings Initiates Tender Offer To Make FANCL A Wholly Owned Subsidiary

Chat via Whatsapp

Ada yang ditanyakan?
Klik untuk chat dengan customer support kami

Iffah
● online
Iffah
● online
Halo, perkenalkan saya Iffah
baru saja
Ada yang bisa saya bantu?
baru saja

Produk yang sangat tepat, pilihan bagus..!

Berhasil ditambahkan ke keranjang belanja
Lanjut Belanja
Checkout
Produk Quick Order

Pemesanan dapat langsung menghubungi kontak dibawah: